Product ID |
Product Name |
CAS# |
Purity |
Y3317733 |
5-Bromo-2-nitrobenzene-1,3-diamine |
2091582-24-8 |
95% |
Y1266821 |
3-bromo-5-(trifluoromethyl)quinoline |
2177257-71-3 |
95% |
Y1302998 |
(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-ethoxypropanoic acid |
1931107-98-0 |
95% |
Y1236163 |
(S)-1-((S)-2-(3,4,5-Trimethoxyphenyl)butanoyl)piperidine-2-carboxylicacid |
195202-09-6 |
98% |
Y3106327 |
7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione |
1911621-52-7 |
98% |
Y3268475 |
3-(((Benzyloxy)carbonyl)amino)-2,6-difluorobenzoic acid |
1877941-02-0 |
95% |
Y1236101 |
6-methoxyisoquinolin-4-amine |
1780189-97-0 |
98% |
Y3264426 |
Methyl 3-amino-1,2,4-triazine-6-carboxylate |
1831085-80-3 |
95% |
Y3261804 |
(5-chloro-2-(difluoromethyl)phenyl)methanol |
1784592-44-4 |
95% |
Y3308290 |
LCL521 |
1226851-11-1 |
99% |
Y1240492 |
EML4-ALK kinase inhibitor 1 |
1373409-08-5 |
98% |
Y1343407 |
FGTI-2734 |
1247018-19-4 |
99% |
Y3318268 |
PPDA-001 |
1805833-75-3 |
95% |
Y1236141 |
Jarin-1 |
1212704-51-2 |
98% |
Y1240423 |
Lp-PLA2-IN-3 |
2196245-16-4 |
99% |
Y1236142 |
PC945 |
1931946-73-4 |
99% |
Y1347707 |
Calcium(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate |
1714147-47-3 |
95% |
Y3259438 |
1-(Pyrimidin-2-yl)-1H-benzo[d]imidazol-2(3H)-one |
1823542-31-9 |
95% |
Y3263821 |
3-Bromobenzo[b]thiophen-7-amine |
1638771-86-4 |
95% |
Y3264053 |
6-(2-fluoropropan-2-yl)picolinic acid |
1785119-80-3 |
95% |
Y1240493 |
Oleanolic acid hemiphthalate disodium salt |
168770-31-8 |
98% |
Y3310750 |
Tat-NR2B9c TFA |
1834571-04-8 |
99% |
Y1236143 |
BPK-29 hydrochloride |
2444815-73-8 |
98% |
Y3272698 |
tert-Butyl7-(aminomethyl)-5-azaspiro[2.4]heptane-5-carboxylate |
1638765-15-7 |
95% |
Y1240426 |
9-[4-(4-bromophenyl)-6-phenyl-1,3,5-triazin-2-yl]-9H-Carbazole |
1616413-67-2 |
98% |
Y3268493 |
tert-Butyl2-amino-7-azaspiro[4.5]decane-7-carboxylate |
1638759-80-4 |
95% |
Y1342820 |
LYN-1604 dihydrochloride |
2310109-38-5 |
98% |
Y3256053 |
2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-ol |
1628866-40-9 |
95% |
Y3306649 |
tert-Butyl 7-(4-(methoxycarbonyl)bicyclo[2.2.2]octan-1-yl)-5-oxa-2,6-diazaspiro[3.4]oct-6-ene-2-carboxylate |
1628749-52-9 |
97% |
Y3295216 |
trans-4-Methyl-N-(5-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-4-(thiophen-2-yl)thiazol-2-yl)cyclohexanecarboxamide |
1620992-67-7 |
99% |
Y3263257 |
1-(6-Fluoro-1H-indol-3-yl)-2-methylpropan-2-amine |
169505-89-9 |
95% |
Y3263208 |
2-Methyl-2-(tetrahydrofuran-3-yl)propanoic acid |
1533545-45-7 |
95% |
Y3265632 |
1,3-Dimethyl-1H-indazole-5-carboxylicacid |
1505140-03-3 |
95% |
Y3271670 |
5-Ethylpyrimidine-2-carboxylicacid |
1554782-53-4 |
95% |
Y3272112 |
methyl 4-benzyl-4H-1,2,4-triazole-3-carboxylate |
1499224-49-5 |
95% |
Y3109977 |
4,4-difluoro-2-(4-fluorophenyl)butanoic acid |
1538957-14-0 |
98% |
Y3296170 |
Alicapistat |
1254698-46-8 |
98% |
Y1240494 |
DDD107498 succinate |
2444781-71-7 |
99% |
Y1240451 |
FT895 |
2225728-57-2 |
99% |
Y1236079 |
SMS2-IN-2 |
2241838-28-6 |
98% |
Y3285708 |
GB-88 |
1416435-96-5 |
99% |
Y1240427 |
CORM-401 |
1001015-18-4 |
98% |
Y3292563 |
Tyk2-IN-5 |
1797432-62-2 |
98% |
Y1236071 |
Methuosis inducer 1 |
2240205-30-3 |
98% |
Y3315190 |
GMB-475 |
2490599-18-1 |
98% |
Y3297528 |
BI-4916 |
2244451-48-5 |
98% |
Y3294185 |
MV1 |
1001600-54-9 |
99% |
Y3287854 |
Nanatinostat |
1256448-47-1 |
99% |
Y1242372 |
BIIL-260 hydrochloride |
192581-24-1 |
99% |
Y3107153 |
ML604440 |
1140517-08-3 |
98% |
Y1242461 |
HSL-IN-1 |
2095156-13-9 |
98% |
Y3101933 |
(+)-SHIN1 |
2443966-90-1 |
99% |
Y3102235 |
5-chloro-2-(difluoromethyl)benzoic acid |
1551365-62-8 |
95% |
Y1237906 |
CDC25B-IN-1 |
2374831-10-2 |
98% |
Y1343131 |
Mcl1-IN-8 |
678158-55-9 |
98% |
Y1242330 |
UPGL00004 |
1890169-95-5 |
98% |
Y1237931 |
VU0364770 hydrochloride |
1414842-70-8 |
99% |
Y1237908 |
SWE101 |
2376322-12-0 |
99% |
Y3151464 |
L,L-Dityrosine |
63442-81-9 |
99% |
Y1242332 |
LT052 |
2543545-44-2 |
98% |
Y3151648 |
Odevixibat |
501692-44-0 |
99% |
Y1242392 |
hDHODH-IN-4 |
1644156-56-8 |
99% |
Y3151646 |
IRAK4-IN-6 |
2454244-02-9 |
99% |
Y3288951 |
(1a,1'S,4ß)-Lanabecestat |
1384082-96-5 |
96% |
Y3293655 |
L-692429 |
145455-23-8 |
99% |
Y1242474 |
Cdc7-IN-5 |
1402057-86-6 |
95% |
Y1242393 |
BIZ 114 |
2099120-74-6 |
98% |
Y1242462 |
GDC-0276 |
1494581-70-2 |
99% |
Y3293278 |
Nav1.1 activator 1 |
2332897-85-3 |
99% |
Y3151554 |
P2X3 antagonist 34 |
2417288-67-4 |
99% |
Y3151649 |
4-Methylisothiazole-3-carboxylic acid |
1507952-32-0 |
95% |
Y1343149 |
Mobocertinib succinate |
2389149-74-8 |
99% |
Y1242464 |
FGI-106 tetrahydrochloride |
1149348-10-6 |
99% |
Y1342813 |
AZD-9833 |
2222844-89-3 |
98% |
Y3109680 |
2-bromo-2,2-difluoro-1-morpholinoethan-1-one |
149229-27-6 |
95% |
Y3257684 |
Facinicline hydrochloride |
677305-02-1 |
99% |
Y1242447 |
KSC-34 |
2226201-97-2 |
99% |
Y3151535 |
Tofacitinib metabolite-1 |
1640971-51-2 |
98% |
Y3297688 |
PI3Ka-IN-4 |
2322293-83-2 |
99% |
Y1242395 |
ZT-1a |
212135-62-1 |
99% |
Y3309864 |
1-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-2-yl)ethanone |
1491162-68-5 |
95% |
Y1242403 |
BCL6-IN-5 |
2253878-09-8 |
99% |
Y3110624 |
Rp-cAMPS sodium salt |
142439-94-9 |
99% |
Y1242437 |
HBV-IN-4 |
2305897-84-9 |
99% |
Y1242478 |
Nepinalone hydrochloride |
22443-55-6 |
99% |
Y1339858 |
Methyl7-fluoro-1H-indazole-5-carboxylate |
1427431-00-2 |
98% |
Y1247416 |
(Rac)-PF-06256142 |
1609580-97-3 |
99% |
Y1247448 |
LUF6096 |
1116652-18-6 |
99% |
Y3314700 |
10-Hydroxy majoroside |
259753-12-3 |
97.0% |
Y1243034 |
HKGreen-4I |
1448821-82-6 |
99% |
Y1243035 |
HKOH-1 |
2031170-96-2 |
98% |
Y1247452 |
HKOH-1r |
2138472-08-7 |
97% |
Y1243018 |
Naph-EA-mal |
210292-65-2 |
95% |
Y3309755 |
Arg-Gly-Asp-Cys TFA |
2171504-22-4 |
99% |
Y1251674 |
KL201 |
302939-48-6 |
98% |
Y1247376 |
VRK-IN-1 |
2378855-09-3 |
99% |
Y1247453 |
MAT2A inhibitor 3 |
2439271-82-4 |
98% |
Y3294623 |
Chitopentaose pentahydrochloride |
117467-64-8 |
95.0%(LC&T) |
Y1251676 |
COQ7-IN-2 |
2579696-76-5 |
99% |
Y1247389 |
Rhodamine-N3 chloride |
2363751-90-8 |
97% |